522644-14-0

Basic information

• Product Name: N^α-tert-butoxycarbonyl-N^ε-(1-benzyloxy-1,2-dihydro-2-oxopyrimidin-4-yl)-L-lysine methyle ester
• Synonyms: N^α-tert-butoxycarbonyl-N^ε-(1-benzyloxy-1,2-dihydro-2-oxopyrimidin-4-yl)-L-lysine methyle ester
• CAS NO: 522644-14-0
• Molecular Weight: 460.53
• Mol File: 522644-14-0.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: N^α-tert-butoxycarbonyl-N^ε-(1-benzyloxy-1,2-dihydro-2-oxopyrimidin-4-yl)-L-lysine methyle ester(CAS DataBase Reference)
• NIST Chemistry Reference: N^α-tert-butoxycarbonyl-N^ε-(1-benzyloxy-1,2-dihydro-2-oxopyrimidin-4-yl)-L-lysine methyle ester(522644-14-0)
• EPA Substance Registry System: N^α-tert-butoxycarbonyl-N^ε-(1-benzyloxy-1,2-dihydro-2-oxopyrimidin-4-yl)-L-lysine methyle ester(522644-14-0)

Safety Data

• Hazardous Substances Data: 522644-14-0(Hazardous Substances Data)

Upstream product

• 55757-60-3 N-α-(tert-butoxycarbonyl)-L-lysine methyl ester 
• 219992-65-1 1-(benzyloxy)-4-(1′,2′,4′-triazol-1′-yl)-2-(1H)-pyrimidinone 

Downstream Products

• 522644-22-0 N^α-tert-butoxycarbonyl-N^ε-(1-benzyloxy-1,2-dihydro-2-oxopyrimidin-4-yl)-L-lysine 
• 522644-28-6 C₆₅H₈₅N₁₅O₁₅ 
• 522644-19-5 N^α-tert-butoxycarbonyl-N^ε-(1-benzyloxy-1,2-dihydro-2-oxopyrimidin-4-yl)-L-lysyl-β-alanyl N^ε-(1-benzyloxy-1,2-dihydro-2-oxopyrimidin-4-yl)-L-lysyl-β-alanyl-N^ε-(1-benzyloxy-1,2-dihydro-2-oxopyrimidin-4-yl)-L-lysyl-β-alanine methyl ester 
• 522644-18-4 N^α-tert-butoxycarbonyl-N^ε-(1-benzyloxy-1,2-dihydro-2-oxopyrimidin-4-yl)-L-lysyl-β-alanyl-N^ε-(1-benzyloxy-1,2-dihydro-2-oxopyrimidin-4-yl)-L-lysyl-β-alanine methyl ester 
• 522644-16-2 N^α-tert-butoxycarbonyl-N^ε-(1-benzyloxy-1,2-dihydro-2-oxopyrimidin-4-yl)-L-lysyl-β-alanine 
• 522644-15-1 N^α-tert-butoxycarbonyl-N^ε-(1-benzyloxy-1,2-dihydro-2-oxopyrimidin-4-yl)-L-lysyl-β-alanine methyl ester 

Relevant articles and documents

Synthesis of linear and cyclic hexapeptides with Nε-(1,2-dihydro-1-hydroxy-2-oxopyrimidin-4-yl) -L-lysyl-β-alanyl as the repeating unit and properties of their iron(III) complexes

Linear and cyclic hexapeptides including Nε(1,2-dihydro-1-hydroxy-2-oxopyrimidin-4-yl) -L-lysyl-β-alanyl as the repeating unit have been synthesized. These hexapeptides formed 1:1 iron(III) complexes; λmax 466 nm and ε 4700 for a linear hexapeptide (8), and λmax 458 nm and ε 4300 for a cyclic hexapeptide (9). The relative stability constants of 8- and 9-iron(III) complexes were estimated to be 26.1 and 28.0, respectively. A linear hexapeptide (8)-iron(III) complex predominantly existed in Δ-configuration. From kinetic data on iron(III) removal from human transferrin, a linear hexapeptides (8) was found to efficiently remove three times as much iron(III) from transferrin as desferrioxamine B, only a chemotherapeutic agent for the iron overload disease.